Ahmad Abu-Arafeh
A5069766768- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Cardiac Arrest and Resuscitation
- Thermal Regulation in Medicine
- SARS-CoV-2 and COVID-19 Research
- Respiratory Support and Mechanisms
- Intensive Care Unit Cognitive Disorders
- Mechanical Circulatory Support Devices
- Traumatic Brain Injury and Neurovascular Disturbances
- Coronary Artery Anomalies
- Heparin-Induced Thrombocytopenia and Thrombosis
- SARS-CoV-2 detection and testing
- Kawasaki Disease and Coronary Complications
- Cardiac Structural Anomalies and Repair
- Neuroendocrine Tumor Research Advances
- Chemotherapy-related skin toxicity
- Cardiac, Anesthesia and Surgical Outcomes
- Pneumonia and Respiratory Infections
- Cancer Treatment and Pharmacology
- Venous Thromboembolism Diagnosis and Management
- Hemodynamic Monitoring and Therapy
- Nausea and vomiting management
- Diabetes Treatment and Management
- Colorectal Cancer Treatments and Studies
- Anesthesia and Neurotoxicity Research
Western General Hospital
2022-2024
NHS Lothian
2017-2024
Edinburgh Royal Infirmary
2016-2023
NIHR Clinical Research Network
2021
National Institute for Health Research
2021
National Records of Scotland
2021
Intensive Care National Audit & Research Centre
2021
Public Health Scotland
2021
University Hospitals Birmingham NHS Foundation Trust
2021
Public Health England
2021
BackgroundMany patients with COVID-19 have been treated plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent therapy in admitted hospital COVID-19.MethodsThis randomised, controlled, open-label, platform trial (Randomised Evaluation Therapy [RECOVERY]) is assessing several possible treatments hospitalised UK. The underway at 177 NHS hospitals from across Eligible consenting were randomly assigned (1:1) receive either usual care alone...
BackgroundAspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate efficacy and safety aspirin in patients admitted hospital with COVID-19.MethodsIn this randomised, controlled, open-label, platform trial, several possible treatments were compared usual care hospitalised COVID-19. The trial took place at 177 hospitals UK, two Indonesia, Nepal. Eligible consenting adults randomly allocated 1:1 ratio either standard plus 150 mg...
BackgroundEmpagliflozin has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory, metabolic, and haemodynamic effects. The RECOVERY trial aimed to assess safety efficacy in patients admitted hospital with COVID-19.MethodsIn randomised, controlled, open-label trial, several possible treatments are compared usual care hospitalised COVID-19. In this analysis, we eligible consenting adults who were randomly allocated 1:1 ratio either standard alone or plus oral...
Anticipated sequelae of critical care admission for COVID-19 disease remain unclear. Our Edinburgh-based follow-up service identified patterns with nerve injury in 13 35 patients who attended following a between 15/03/2020 and 25/12/2020. This included 7 cases meralgia parasthetica, 1 brachial plexopathy, 2 common peroneal neuropathies 3 ulnar neuropathies. All upper limb neuropathy foot drop occurred whom prone positioning was used, parasthetica occurring additionally remained supine.
The Eurotherm3235 trial showed that therapeutic hypothermia was deleterious in patients with raised intracranial pressure following traumatic brain injury. We sought to ascertain if increased temperature variability within the first 48 hours, or for 7 days post randomization, were modifiable risk factors associated poorer outcome.Eurotherm3235 a multicenter randomized controlled trial. Patients receive either addition standard care later only. Mean moving range (mr) used stratify subjects...
Background: Despite high rates of cardiovascular disease in Scotland, the prevalence and outcomes patients with cardiogenic shock are unknown. Methods: We undertook a prospective observational cohort study consecutive admitted to intensive care unit (ICU) or coronary at 13 hospitals Scotland for 6-month period. Denominator data from Scottish Intensive Care Society Audit Group were used estimate ICU prevalence; units unavailable. multivariable logistic regression identify factors associated...